This inventor holds 1 USPTO granted patent. Top assignee: Amalive Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xiaofeng Wang Rears: Patent Activity in Liver Disease Treatment.
Introduction
Xiaofeng Wang Rears is an inventor associated with Boston, Massachusetts, and Amalive Limited. His patent work concerns ornithine phenylacetate and its potential use in treating hyperammonemia.
Latest Patents
The available information lists 1 patent for Xiaofeng Wang Rears: “Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia.” The patent describes doses and methods of administering ornithine phenylacetate to treat or ameliorate hyperammonemia in patients with chronic liver disease, such as cirrhosis. Some embodiments also address patients with hepatic encephalopathy as a complication of liver disease.
Career Highlights
Wang Rears’s listed patent activity focuses on a therapeutic approach to hyperammonemia associated with chronic liver disease. The available details identify Amalive Limited as the company with which he is associated.
Collaborations
The listed coworkers associated with Wang Rears include Susan VanMeter and Nagaraju Poola.
Conclusion
Xiaofeng Wang Rears’s documented invention centers on ornithine phenylacetate dosing and administration for hyperammonemia, including in patients with chronic liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile